Description

Genomind is a line of saliva-based neurotransmitter sensing solutions designed for healthcare industries. These solutions enable users to assess patient’s genetics to streamline dosing and medication choices; identify gene and drug interaction risks; stratify patient populations based on risk for drug-drug and potential gene-drug interactions; use multiple filtering options to find patients; utilize the online patient portal to access results, and track mental health; shift the medication position left or right based on known gene-drug interactions; inform treatment decisions focused on depression and anxiety. Features include wearables for health monitoring, electrochemical detection, in-vivo detections, electrochemical monitoring, and psychiatric medication. Solutions include Pharmacogenetic testing, precision medicine software, precision-medicine consults, and population health.